S&P 500   4,594.62 (-2.27%)
DOW   34,899.34 (-2.53%)
QQQ   391.20 (-1.90%)
AAPL   156.81 (-3.17%)
MSFT   329.68 (-2.44%)
FB   333.12 (-2.33%)
GOOGL   2,843.66 (-2.69%)
AMZN   3,504.56 (-2.12%)
TSLA   1,081.92 (-3.05%)
NVDA   315.03 (-3.58%)
BABA   133.35 (-2.32%)
NIO   39.99 (-3.45%)
CGC   11.69 (-1.52%)
AMD   154.81 (-1.89%)
GE   97.84 (-4.29%)
MU   83.42 (-3.24%)
T   24.22 (-1.02%)
F   19.75 (-2.47%)
DIS   148.11 (-2.13%)
ACB   6.79 (+0.15%)
AMC   37.63 (-3.24%)
PFE   54.00 (+6.11%)
BA   199.21 (-5.41%)
S&P 500   4,594.62 (-2.27%)
DOW   34,899.34 (-2.53%)
QQQ   391.20 (-1.90%)
AAPL   156.81 (-3.17%)
MSFT   329.68 (-2.44%)
FB   333.12 (-2.33%)
GOOGL   2,843.66 (-2.69%)
AMZN   3,504.56 (-2.12%)
TSLA   1,081.92 (-3.05%)
NVDA   315.03 (-3.58%)
BABA   133.35 (-2.32%)
NIO   39.99 (-3.45%)
CGC   11.69 (-1.52%)
AMD   154.81 (-1.89%)
GE   97.84 (-4.29%)
MU   83.42 (-3.24%)
T   24.22 (-1.02%)
F   19.75 (-2.47%)
DIS   148.11 (-2.13%)
ACB   6.79 (+0.15%)
AMC   37.63 (-3.24%)
PFE   54.00 (+6.11%)
BA   199.21 (-5.41%)
S&P 500   4,594.62 (-2.27%)
DOW   34,899.34 (-2.53%)
QQQ   391.20 (-1.90%)
AAPL   156.81 (-3.17%)
MSFT   329.68 (-2.44%)
FB   333.12 (-2.33%)
GOOGL   2,843.66 (-2.69%)
AMZN   3,504.56 (-2.12%)
TSLA   1,081.92 (-3.05%)
NVDA   315.03 (-3.58%)
BABA   133.35 (-2.32%)
NIO   39.99 (-3.45%)
CGC   11.69 (-1.52%)
AMD   154.81 (-1.89%)
GE   97.84 (-4.29%)
MU   83.42 (-3.24%)
T   24.22 (-1.02%)
F   19.75 (-2.47%)
DIS   148.11 (-2.13%)
ACB   6.79 (+0.15%)
AMC   37.63 (-3.24%)
PFE   54.00 (+6.11%)
BA   199.21 (-5.41%)
S&P 500   4,594.62 (-2.27%)
DOW   34,899.34 (-2.53%)
QQQ   391.20 (-1.90%)
AAPL   156.81 (-3.17%)
MSFT   329.68 (-2.44%)
FB   333.12 (-2.33%)
GOOGL   2,843.66 (-2.69%)
AMZN   3,504.56 (-2.12%)
TSLA   1,081.92 (-3.05%)
NVDA   315.03 (-3.58%)
BABA   133.35 (-2.32%)
NIO   39.99 (-3.45%)
CGC   11.69 (-1.52%)
AMD   154.81 (-1.89%)
GE   97.84 (-4.29%)
MU   83.42 (-3.24%)
T   24.22 (-1.02%)
F   19.75 (-2.47%)
DIS   148.11 (-2.13%)
ACB   6.79 (+0.15%)
AMC   37.63 (-3.24%)
PFE   54.00 (+6.11%)
BA   199.21 (-5.41%)
NASDAQ:ULBI

Ultralife Stock Forecast, Price & News

$5.53
-0.05 (-0.90%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$5.38
$5.56
50-Day Range
$5.53
$7.49
52-Week Range
$5.38
$11.78
Volume
19,553 shs
Average Volume
230,855 shs
Market Capitalization
$88.93 million
P/E Ratio
30.72
Dividend Yield
N/A
Beta
1.55
30 days | 90 days | 365 days | Advanced Chart
Receive ULBI News and Ratings via Email

Sign-up to receive the latest news and ratings for Ultralife and its competitors with MarketBeat's FREE daily newsletter.


Ultralife logo

About Ultralife

Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the Battery & Energy Products and Communications System segments. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables. The Communications System segment comprises radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design. The company was founded by Arthur M. Liberman in December 1990 and is headquartered in Newark, NY.

Headlines

I'm Rolling Out My New Active and Passive Portfolios - RealMoney
October 15, 2021 |  realmoney.thestreet.com
See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous electrical machinery, equipment, & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:ULBI
Employees
532
Year Founded
1990

Sales & Book Value

Annual Sales
$107.71 million
Cash Flow
$0.58 per share
Book Value
$7.37 per share

Profitability

Net Income
$5.23 million
Pretax Margin
3.85%

Debt

Price-To-Earnings

Miscellaneous

Free Float
9,906,000
Market Cap
$88.93 million
Optionable
Optionable

Company Calendar

Last Earnings
10/28/2021
Today
11/26/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/03/2022

Social Links


MarketRank

Overall MarketRank

2.14 out of 5 stars

Computer And Technology Sector

354th out of 890 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

8th out of 29 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -












Ultralife (NASDAQ:ULBI) Frequently Asked Questions

Is Ultralife a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ultralife in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Ultralife stock.
View analyst ratings for Ultralife
or view top-rated stocks.

How has Ultralife's stock been impacted by Coronavirus (COVID-19)?

Ultralife's stock was trading at $6.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ULBI shares have decreased by 14.1% and is now trading at $5.53.
View which stocks have been most impacted by COVID-19
.

When is Ultralife's next earnings date?

Ultralife is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for Ultralife
.

How were Ultralife's earnings last quarter?

Ultralife Co. (NASDAQ:ULBI) announced its earnings results on Thursday, October, 28th. The technology company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of $0.08 by $0.12. The technology company earned $21.76 million during the quarter. Ultralife had a net margin of 2.90% and a trailing twelve-month return on equity of 3.13%.
View Ultralife's earnings history
.

What price target have analysts set for ULBI?

1 Wall Street analysts have issued 12-month price objectives for Ultralife's shares. Their forecasts range from $12.00 to $12.00. On average, they anticipate Ultralife's stock price to reach $12.00 in the next twelve months. This suggests a possible upside of 117.0% from the stock's current price.
View analysts' price targets for Ultralife
or view top-rated stocks among Wall Street analysts.

Who are Ultralife's key executives?

Ultralife's management team includes the following people:
  • Michael D. Popielec, President, Chief Executive Officer & Director
  • Philip A. Fain, Chief Financial Officer, Secretary & Treasurer

What other stocks do shareholders of Ultralife own?

What is Ultralife's stock symbol?

Ultralife trades on the NASDAQ under the ticker symbol "ULBI."

Who are Ultralife's major shareholders?

Ultralife's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (6.88%), Monarch Partners Asset Management LLC (2.34%), Janney Montgomery Scott LLC (2.22%), Victory Capital Management Inc. (2.10%), Renaissance Technologies LLC (1.53%) and Russell Investments Group Ltd. (1.01%). Company insiders that own Ultralife stock include Bradford T Whitmore, Philip A Fain and W Shaw Robert.
View institutional ownership trends for Ultralife
.

Which institutional investors are selling Ultralife stock?

ULBI stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Renaissance Technologies LLC, Allianz Asset Management GmbH, Russell Investments Group Ltd., Victory Capital Management Inc., Dimensional Fund Advisors LP, and BlackRock Inc..
View insider buying and selling activity for Ultralife
or view top insider-selling stocks.

Which institutional investors are buying Ultralife stock?

ULBI stock was bought by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, Janney Montgomery Scott LLC, and Geode Capital Management LLC. Company insiders that have bought Ultralife stock in the last two years include Bradford T Whitmore, Philip A Fain, and W Shaw Robert.
View insider buying and selling activity for Ultralife
or or view top insider-buying stocks.

How do I buy shares of Ultralife?

Shares of ULBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ultralife's stock price today?

One share of ULBI stock can currently be purchased for approximately $5.53.

How much money does Ultralife make?

Ultralife has a market capitalization of $88.93 million and generates $107.71 million in revenue each year. The technology company earns $5.23 million in net income (profit) each year or $0.18 on an earnings per share basis.

How many employees does Ultralife have?

Ultralife employs 532 workers across the globe.

Does Ultralife have any subsidiaries?

The following companies are subsidiares of Ultralife: ABLE New Energy Co. Limited, Accutronics Ltd., CLB Inc., Southwest Electronic Energy Corporation, Ultralife Batteries (UK) LTD, Ultralife Batteries India Private Limited, Ultralife Energy Services Corporation, and Ultralife UK LTD.

When was Ultralife founded?

Ultralife was founded in 1990.

What is Ultralife's official website?

The official website for Ultralife is www.ultralifecorporation.com.

Where are Ultralife's headquarters?

Ultralife is headquartered at 2000 TECHNOLOGY PARKWAY, NEWARK NY, 14513.

How can I contact Ultralife?

Ultralife's mailing address is 2000 TECHNOLOGY PARKWAY, NEWARK NY, 14513. The technology company can be reached via phone at (315) 332-7100 or via fax at 315-331-7800.


This page was last updated on 11/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.